A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of oxaliplatin given synchronously with 5-fluorouracil (5FU), leucovorin (LV) and preoperative pelvic radiation for primary unresectable, locally advanced, rectal cancer. Preoperative pelvic radiotherapy...
Hauptverfasser: | Sebag-Montefiore, D, Glynne-Jones, R, Falk, S, Meadows, H, Maughan, T |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2005
|
Ähnliche Einträge
Ähnliche Einträge
-
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
von: Glynne-Jones, R, et al.
Veröffentlicht: (2007) -
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
von: Glynne-Jones, R, et al.
Veröffentlicht: (2004) -
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
von: Glynne-Jones, R, et al.
Veröffentlicht: (2005) -
OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
von: Deyan N. Davidov
Veröffentlicht: (2013-12-01) -
Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
von: Zhao Y, et al.
Veröffentlicht: (2021-01-01)